Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

ROLE OF CYP2E1 IN DERAMCICLANE METABOLISM

Katalin Monostory, Krisztina Köhalmy, Eszter Hazai, László Vereczkey and László Kóbori
Drug Metabolism and Disposition November 2005, 33 (11) 1717-1722; DOI: https://doi.org/10.1124/dmd.105.003772
Katalin Monostory
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Krisztina Köhalmy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eszter Hazai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
László Vereczkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
László Kóbori
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The aim of our study was to identify the form(s) of cytochrome P450 responsible for the metabolism of deramciclane, a new anxiolytic drug candidate. The main routes of biotransformation in hepatic microsomes were side chain modification (N-demethylation or total side chain cleavage) and hydroxylation at several points of the molecule. Although several cytochrome P450 forms were involved in the metabolism, the role of CYP2E1 should be emphasized, since it catalyzed almost all steps. Production of deramciclane metabolites was significantly inhibited by diethyl-dithiocarbamate and was elevated in liver microsomes of isoniazid-treated rats. Furthermore, cDNA-expressed rat CYP2E1 generated the metabolites formed by side chain modification and hydroxylation. Neither deramciclane nor its primary metabolite, N-desmethyl deramciclane were able to influence directly the activity of CYP2E1. However, during the biotransformation, one or more metabolites must have been formed which were potent inhibitors of CYP2E1.

Footnotes

  • Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.

  • doi:10.1124/dmd.105.003772.

  • ABBREVIATIONS: P450, cytochrome P450; HPLC, high-performance liquid chromatography; deramciclane, (1R,2S,4R)-(–)-2-phenyl-2-(2′-dimethylamino-ethoxy)-1,7,7-trimethyl-bicyclo[2.2.1]heptane; N-desmethyl-deramciclane (M4), (1R,2S,4R)-(–)-2-phenyl-2-(2′-methylamino-ethoxy)-1,7,7-trimethyl-bicyclo[2.2.1]heptane; 9-hydroxy-deramciclane (M5), (1R,2S,4R,7R)-2-(2′-dimethylamino-ethoxy)-2-phenyl-7-(hydroxy-methyl)-1,7-dimethylbicyclo[2.2.1]heptane; N-desmethyl 9-hydroxy-deramciclane (M2), (1R,2S,4R,7R)-2-(2′-methyl-amino-ethoxy)-2-phenyl-7-(hydroxy-methyl)-1,7-dimethyl-bicyclo[2.2.1]heptane; hydroxy-deramciclane II (M6), (1R,2S,4R)-(–)-2-phenyl-2-(2′-dimethylamino-ethoxy)-5 or 6-hydroxy-1,7,7-trimethyl-bicyclo[2.2.1]heptane; N-desmethyl hydroxy-deramciclane II (M3), (1R,2S,4R)-(–)-2-phenyl-2-(2′-methylamino-ethoxy)-5 or 6-hydroxy-1,7,7-trimethyl-bicyclo[2.2.1]heptane, phenylborneol, (1R,2S,4R)-(–)-2-hydroxy-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane.

    • Received January 19, 2005.
    • Accepted May 27, 2005.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 33 (11)
Drug Metabolism and Disposition
Vol. 33, Issue 11
1 Nov 2005
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
ROLE OF CYP2E1 IN DERAMCICLANE METABOLISM
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

ROLE OF CYP2E1 IN DERAMCICLANE METABOLISM

Katalin Monostory, Krisztina Köhalmy, Eszter Hazai, László Vereczkey and László Kóbori
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1717-1722; DOI: https://doi.org/10.1124/dmd.105.003772

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

ROLE OF CYP2E1 IN DERAMCICLANE METABOLISM

Katalin Monostory, Krisztina Köhalmy, Eszter Hazai, László Vereczkey and László Kóbori
Drug Metabolism and Disposition November 1, 2005, 33 (11) 1717-1722; DOI: https://doi.org/10.1124/dmd.105.003772
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • rs2242480 Regulates the Expression of CYP3A4 and CYP3A5
  • Absorption, Metabolism, and Excretion of Taselisib
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics